- Home
- Clinical Trials
- SWOG 1826 A Phase III, Randomized Study of Nivolumab (Opdivo) plus AVD or Brentuximab Vedotin (Adcetris) plus AVD in Patients (Age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
What You Need To Know: Temporary Visitor Restrictions | COVID-19 Vaccine